POST Online Media Lite Edition


Bausch + Lomb: Fred Hassan chairman, Brent Saunders CEO

Staff writer |
Rochester, N.Y., USA - March 15, 2010, Rochester, N.Y., USA - Bausch + Lomb, a global eye health company, has named Fred Hassan as chairman of the board of directors and Brent Saunders as chief executive officer and director, effective immediately.

Mr. Hassan is one of the leading figures in global healthcare. He served most recently as chairman and CEO of Schering-Plough Corporation until its merger with Merck & Co. in November 2009. He led a six-year transformation of Schering-Plough from a company under severe stress into one of the highest performing companies in the research-based global pharmaceutical industry, with a rich late-stage pipeline.

Previously Mr. Hassan was chairman and CEO of Pharmacia Corporation, where he also executed a historic turnaround. Earlier in his career, Mr. Hassan was president of the U.S. operations of Wyeth and held positions of increasing importance at Novartis. He has served as a senior advisor to Warburg Pincus LLC, the private equity investing group, since November 2009. Warburg Pincus is the majority owner of Bausch + Lomb.

Mr. Saunders was previously senior vice president and president of Schering-Plough's Consumer Healthcare unit, where he implemented a successful growth strategy including expansion into international markets. As a member of Schering-Plough's six-person executive committee, Mr. Saunders also played a key role in the transformation of the company.


What to read next

Cisco appoints Brenton L. Saunders to board
Bausch & Lomb Japan named Francisco Ascencion as president
Amgen announces appointment of Fred Hassan to board of directors